{"id":"W2761911056","doi":"10.1200/jco.2017.35.15_suppl.e15753","title":"A study of REOLYSIN in combination with pembrolizumab and chemotherapy in patients (pts) with relapsed metastatic adenocarcinoma of the pancreas (MAP).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Chills; Pembrolizumab; Internal medicine; Gastroenterology; Chemotherapy; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009079303,0.0008084386,0.002181075,0.0003437149,0.0004071772,0.000809832,0.000537282,0.0009732887,0.002513003],"category_scores_gemma":[0.0008599029,0.0004840883,0.001133279,0.0004450502,0.0005139112,0.0007847549,0.0003421488,0.001902064,0.0005710353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008740303,"about_ca_system_score_gemma":0.001113983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007190028,"about_ca_topic_score_gemma":0.002075543,"domain_scores_codex":[0.9995704,0.0002122971,0.00002861698,0.00008017996,0.00004163698,0.00006690821],"domain_scores_gemma":[0.9994677,0.00009846875,0.0001066275,0.00003074731,0.00003216647,0.0002643356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7034677,0.09883296,0.02789441,0.001351171,0.002516557,0.001112099,0.0006938587,0.002219182,0.05128609,0.0002424128,0.001778399,0.1086052],"study_design_scores_gemma":[0.1512733,0.8041164,0.03483642,0.00005569408,0.0009360321,0.000548426,0.0001378224,0.0008780216,0.003041824,0.00008358368,0.004062072,0.00003050748],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956979,0.001791992,0.0001688839,0.0002072528,0.00006568306,0.0008440893,0.0002104004,0.00001626399,0.0009976238],"genre_scores_gemma":[0.9961615,0.00102488,0.0004831637,0.0002878922,0.0001471434,0.0007592379,0.0003317271,0.000005535018,0.0007989589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002513003,"threshold_uncertainty_score":0.008406818,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05148698062257427,"score_gpt":0.4093924292765623,"score_spread":0.357905448653988,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}